Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rang în acțiuni #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Preț acțiune
$0.09933121
Capitalizare de piață
$29.15K
Schimbare (1 zi)
0.57%
Schimbare (1 an)
449.49%
Țară
IE
Tranzacționează Ovoca Bio plc (OVB)

Categorie

Venituri pentru Ovoca Bio plc (OVB)
Venituri în Jun 2024 TTM: 0.00
Conform celor mai recente rapoarte financiare ale Ovoca Bio plc, venitul actual al companiei (TTM) este 0.00. În anul 2023, compania a avut un venit de 0.00 egal cu venitul din anul 2022, care a fost de 0.00. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Ovoca Bio plc din 2001 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
$48.44B -
DK
$12.04B -
US
$14.34B -
US
$9.08B -
BE
$5.49B -
NL